PIRMELLA 1/35 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pirmella 1/35, and when can generic versions of Pirmella 1/35 launch?
Pirmella 1/35 is a drug marketed by Lupin Ltd and is included in one NDA.
The generic ingredient in PIRMELLA 1/35 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for PIRMELLA 1/35
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PIRMELLA 1/35 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PIRMELLA 1/35
US Patents and Regulatory Information for PIRMELLA 1/35
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupin Ltd | PIRMELLA 1/35 | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 201512-001 | Apr 24, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |